Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 3
1(25.0%)
4Total
N/A(3)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT02598765Not ApplicableCompleted

Micro vs. Standard Trabeculectomy Study

Role: collaborator

NCT07377513Not ApplicableNot Yet Recruiting

Follow-up Compliance for Corneal Ulcer Patients With SMS Reminder

Role: collaborator

NCT04834648Not ApplicableCompleted

Improve Timely Referral Flow and Compliance of Diabetic Retinopathy Patients

Role: collaborator

NCT00997035Phase 3Completed

The Mycotic Ulcer Treatment Trial II: A Randomized Trial Comparing Oral Voriconazole vs Placebo

Role: collaborator

All 4 trials loaded